These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24204009)

  • 1. Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity.
    Fosgerau K; Raun K; Nilsson C; Dahl K; Wulff BS
    J Endocrinol; 2014 Feb; 220(2):97-107. PubMed ID: 24204009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression.
    Li G; Zhang Y; Wilsey JT; Scarpace PJ
    J Endocrinol; 2004 Jul; 182(1):123-32. PubMed ID: 15225137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques.
    Kievit P; Halem H; Marks DL; Dong JZ; Glavas MM; Sinnayah P; Pranger L; Cowley MA; Grove KL; Culler MD
    Diabetes; 2013 Feb; 62(2):490-7. PubMed ID: 23048186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feeding response to melanocortin agonist predicts preference for and obesity from a high-fat diet.
    Chandler PC; Viana JB; Oswald KD; Wauford PK; Boggiano MM
    Physiol Behav; 2005 Jun; 85(2):221-30. PubMed ID: 15893778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding.
    Harrold JA; Widdowson PS; Williams G
    Diabetes; 1999 Feb; 48(2):267-71. PubMed ID: 10334300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity.
    Pierroz DD; Ziotopoulou M; Ungsunan L; Moschos S; Flier JS; Mantzoros CS
    Diabetes; 2002 May; 51(5):1337-45. PubMed ID: 11978628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central administration of melanocortin agonist increased insulin sensitivity in diet-induced obese rats.
    Banno R; Arima H; Hayashi M; Goto M; Watanabe M; Sato I; Ozaki N; Nagasaki H; Ozaki N; Oiso Y
    FEBS Lett; 2007 Mar; 581(6):1131-6. PubMed ID: 17321524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor.
    Abbott CR; Rossi M; Kim M; AlAhmed SH; Taylor GM; Ghatei MA; Smith DM; Bloom SR
    Brain Res; 2000 Jun; 869(1-2):203-10. PubMed ID: 10865075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withaferin A inhibits adipogenesis in 3T3-F442A cell line, improves insulin sensitivity and promotes weight loss in high fat diet-induced obese mice.
    Khalilpourfarshbafi M; Devi Murugan D; Abdul Sattar MZ; Sucedaram Y; Abdullah NA
    PLoS One; 2019; 14(6):e0218792. PubMed ID: 31226166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors.
    Kim MS; Small CJ; Russell SH; Morgan DG; Abbott CR; alAhmed SH; Hay DL; Ghatei MA; Smith DM; Bloom SR
    J Neuroendocrinol; 2002 Apr; 14(4):276-82. PubMed ID: 11963824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
    Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
    Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
    Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog.
    Gydesen S; Andreassen KV; Hjuler ST; Hellgren LI; Karsdal MA; Henriksen K
    Am J Physiol Endocrinol Metab; 2017 Nov; 313(5):E598-E607. PubMed ID: 28292761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats.
    Hansen G; Jelsing J; Vrang N
    Acta Pharmacol Sin; 2012 Feb; 33(2):194-200. PubMed ID: 22301859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage.
    Giuliani D; Mioni C; Bazzani C; Zaffe D; Botticelli AR; Capolongo S; Sabba A; Galantucci M; Iannone A; Grieco P; Novellino E; Colombo G; Tomasi A; Catania A; Guarini S
    Br J Pharmacol; 2007 Mar; 150(5):595-603. PubMed ID: 17245369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia.
    Lee JH; Bullen JW; Stoyneva VL; Mantzoros CS
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E625-32. PubMed ID: 15522996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin infusion and obesity in mouse cause alterations in the hypothalamic melanocortin system.
    Gout J; Sarafian D; Tirard J; Blondet A; Vigier M; Rajas F; Mithieux G; Begeot M; Naville D
    Obesity (Silver Spring); 2008 Aug; 16(8):1763-9. PubMed ID: 18551122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Selective Bombesin Receptor Subtype 3 Agonist Promotes Weight Loss in Male Diet-Induced-Obese Rats With Circadian Rhythm Change.
    Nio Y; Hotta N; Maruyama M; Hamagami K; Nagi T; Funata M; Sakamoto J; Nakakariya M; Amano N; Okawa T; Arikawa Y; Sasaki S; Okuda S; Kasai S; Habata Y; Nagisa Y
    Endocrinology; 2017 May; 158(5):1298-1313. PubMed ID: 28324017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defense of Elevated Body Weight Setpoint in Diet-Induced Obese Rats on Low Energy Diet Is Mediated by Loss of Melanocortin Sensitivity in the Paraventricular Hypothalamic Nucleus.
    Luchtman DW; Chee MJ; Doslikova B; Marks DL; Baracos VE; Colmers WF
    PLoS One; 2015; 10(10):e0139462. PubMed ID: 26444289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic application of MTII in a rat model of obesity results in sustained weight loss.
    Hamilton BS; Doods HN
    Obes Res; 2002 Mar; 10(3):182-7. PubMed ID: 11886941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.